(NY: VTAK )

0.4386 -0.0114 (-2.53%)
Official Closing Price Updated: 4:10 PM EDT, Sep 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 53,522
Open 0.4500
Bid (Size) 0.4302 (5)
Ask (Size) 0.4484 (2)
Prev. Close 0.4500
Today's Range 0.4265 - 0.4551
52wk Range 0.3751 - 8.400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Catheter Precision, Inc. (NYSE American: VTAK) Reports First Purchase Order for LockeT in the Pacific Northwest Territory
Via ACCESSWIRE
Presentation at European Society of Cardiology Demonstrates VIVO Accuracy in Complex VT Patients
Via ACCESSWIRE

Performance

YTD
-89.13%
-89.13%
1 Month
-80.15%
-80.15%
3 Month
-91.57%
-91.57%
6 Month
-91.40%
-91.40%
1 Year
-91.81%
-91.81%

More News

Read More
Catheter Precision, Inc. (NYSE American:VTAK) Reports First Purchase Order for LockeT in a New US Territory
Via ACCESSWIRE
Catheter Precision, Inc. Announces Closing of $3.6 Million Underwritten Public Offering and Exercise of Overallotment Option
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Gold Falls 1%; MongoDB Shares Spike Higher
Via Benzinga
Crude Oil Down Over 2%; US Core PCE Prices Rise 0.2% In July
Via Benzinga
Exposures Fossil Fuels
Nasdaq Jumps Over 100 Points; Dell Posts Upbeat Results
Via Benzinga
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Catheter Precision, Inc. Announces Pricing of $3.1 Million Underwritten Public Offering
Via ACCESSWIRE
VTAK Stock Earnings: Catheter Precision, Inc. Common Stock Reported Results for Q2 2024
Via InvestorPlace
Catheter Precision, Inc. (NYSE American: VTAK) Reports Q2 2024 Highlights and Operational Performance Report
Via ACCESSWIRE
Catheter Precision, Inc. Announces Publication of LockeT Data in the Journal of Cardiovascular Electrophysiology
Via ACCESSWIRE
LargeCap Big Tech Stocks Report Earnings Today: Discover SmallCap Stocks Inside to Watch Now!
Via AB Newswire
Catheter Precision, Inc. Completes Enrollment of 75 Patients in LockeT-II Study
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
5 Stocks in the News to Watch Now: LGVN, PRSO, SIRI, INBS, VTAK
Via AB Newswire
Exposures Product Safety
Catheter Precision Inc. (NYSE American: VTAK) Moves Forward with Aggressive Expansion Strategy and New Share Structure
Via AB Newswire
Catheter Precision, Inc. Announces the Completion of Patient Follow-up for the VIVO European Registry and New Product Evaluations of VIVO
Via ACCESSWIRE
Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results
Via Benzinga
Exposures Fossil Fuels
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Nasdaq Surges Over 1%; Lexeo Therapeutics Shares Plummet
Via Benzinga
Catheter Precision, Inc. Announces Effectiveness of 1-for-10 Reverse Stock Split
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.